跳至主要内容
临床试验/NCT05255393
NCT05255393已完成不适用

RELEVANT Prevalence of Patient-Reported Lymphedema Following Surgical Management of Cervical or Vulvar Cancer

Memorial Sloan Kettering Cancer Center1 个研究点 分布在 1 个国家目标入组 111 人开始时间: 2022年2月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
111
试验地点
1
主要终点
prevalence of patient-reported lower extremity lymphedema

研究概览

简要总结

The purpose of this study is to collect information that may identify people who are at risk of developing lower extremity lymphedema (LEL) after sentinel lymph node biopsy (SLN) during surgery for early-stage vulvar or cervical cancer, and to improve the quality and accuracy of the information that is given to people who have this procedure.

Please note that, during this study, the researchers will collect information from a questionnaire completed by people who had SLN and LND+/- SLN during surgery for early-stage cervical or vulvar cancer. No form of treatment will be provided as part of the study, and no investigational tests or procedures will be performed.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Presented to MSK with newly diagnosed early-stage cervical cancer of any histologic profile or early stage vulvar cancer of any histologic profile.
  • °Early stage: Stage 1-2
  • Underwent primary surgery at our institution between January 2006 and January
  • Alive at the time of study activation
  • English comprehension
  • Capable of providing informed consent

排除标准

  • Had documented macroscopic evidence of metastatic disease at the time of initial diagnosis

结局指标

主要结局

prevalence of patient-reported lower extremity lymphedema

时间窗: 1 year

Prevalence will be measured using the 13-item questionnaire as reported by the patient.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验